Cue Biopharma Inc Stock (CUE) Forecast
The Cue Biopharma Inc (CUE) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $118.97, representing a +560.59% increase from the current price of $18.01. The highest analyst price target is $103.40, and the lowest is $134.54.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CUE Price Target
Average 237.16 (+1,217% Upside)
Is Cue Biopharma Inc (CUE) A Buy Now?
Oscillators
Buy: 1 · Sell: 0 · Neutral: 6Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, CUE could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on CUE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.46 indicates that CUE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 55.12 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.86 indicates that CUE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 14.09 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of -28.14 indicates that CUE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CUE price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cue Biopharma Inc financial reports and earnings history, Cue Biopharma Inc (CUE) stock could reach $197.11 by 2030, $865.09 by 2040 and $2,039.96 by 2050. See the projected annual prices until 2050 of the Cue Biopharma Inc stock below:
- Cue Biopharma Inc (CUE) is expected to reach an average price of $355.22 in 2035, with a high prediction of $464.62 and a low estimate of $358.22. This indicates an +1,872% change from the last recorded price of $18.01.
- Cue Biopharma Inc (CUE) stock is projected to chart a bullish course in 2040, with an average price target of $677.97, representing an +3,664% change from its current level. The forecast ranges from a conservative $693.87 to a sky-high $865.09.
- Our analysts predict Cue Biopharma Inc (CUE) to change +6,247% by 2045, soaring from $1,148.41 to an average price of $1,143.05, potentially reaching $1,418.94. While $1,148.41 is the low estimate, the potential upside is significant.
- Cue Biopharma Inc (CUE) stock is expected to climb by 2050, reaching an average of $1,688.20, a +9,274% change from its current level. However, a wide range of estimates exists, with high and low targets of $2,039.96 and $1,693.30, respectively, highlighting the market's uncertainty.
Cue Biopharma Inc Stock (CUE) Year by Year Forecast
Cue Biopharma Inc Stock (CUE) Price Forecast for 2026
The predicted value for Cue Biopharma Inc (CUE) in 2026 is set at an average of $32.81. Estimates vary from a peak of $103.40 to a trough of $4.97, indicating an +82.17% surge from the present price of $18.01.
Cue Biopharma Inc Stock (CUE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cue Biopharma Inc (CUE) is $296.84, with a high forecast of $339.79 and a low forecast of $142.28. This indicates an +1,548% increase from the last price of $18.01.
Cue Biopharma Inc Stock (CUE) Price Forecast for 2028
In 2028, Cue Biopharma Inc (CUE) is projected to reach an average price of $240.59, with a high projection of $285.19 and a low estimate of $199.74. This indicates an +1,236% rise from the last price of $18.01.
Cue Biopharma Inc Stock (CUE) Price Forecast for 2029
The 2029 price forecast for Cue Biopharma Inc Stock (CUE) is $204.03 on average, with a high prediction of $239.75 and a low estimate of $194.00. This represents an +1,033% increase from the previous price of $18.01.
Cue Biopharma Inc Stock (CUE) Price Forecast for 2030
Cue Biopharma Inc Stock (CUE) is expected to reach an average price of $148.71 in 2030, with a high forecast of $197.11 and a low forecast of $121.43. This signifies an +725.71% surge from the last price of $18.01.
